Wordt geladen...
Continuous AMD3100 Treatment Worsens Renal Fibrosis through Regulation of Bone Marrow Derived Pro-Angiogenic Cells Homing and T-Cell-Related Inflammation
AMD3100 is a small molecule inhibitor of chemokine receptor type 4 (CXCR4), which is located in the cell membranes of CD34+ cells and a variety of inflammatory cells and has been reported to reduce organ fibrosis in the lung, liver and myocardium. However, the effect of AMD3100 on renal fibrosis is...
Bewaard in:
Gepubliceerd in: | PLoS One |
---|---|
Hoofdauteurs: | , , , , , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Public Library of Science
2016
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4763993/ https://ncbi.nlm.nih.gov/pubmed/26900858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0149926 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|